Delving into the Latest Updates on Shasun Pharmaceuticals Ltd. with Synapse

Overview

Tags

Cardiovascular Diseases

Enzyme

Biosimilar

Disease domain score

A glimpse into the focused therapeutic areas

No Data

Technology Platform

Most used technologies in drug development

Targets

Most frequently developed targets

Top 5 Drug Type	Count

Biosimilar	1
Enzyme	1

Top 5 Target	Count

PLG(Plasminogen)	1

An efficient four step process for the preparation of 5'-O-(4,4'-dimethoxytrityl)-N2-isobutyryl-2'-O-(2-methoxyethyl)-guanosine 1 was developed. Direct 2'-O-alkylation of 2,6-diaminopurine riboside 2 was accomplished via inexpensive and commercially available reagents such as KOH, DMSO and alkyl halides at room temperature in 4-6 hrs. Pure 2'-O-(2-methoxyethyl)-DAPR 3 was isolated by crystallization from methanol. Enzymatic deamination of 3 followed by selective N2-isobutyrylation and 5'-O-dimethoxytritylation furnished desired 1 in high yield and purity. Fully optimized four step synthetic process has been scaled up to the pilot plant level.

Chemical Engineering (Rockville, MD, United States)

Selecting materials of construction

Author: Robert, John

A review.A survey discussing a number of factors beyond chem. compatibility when engineers in the chem. process industries are faced with the selection of materials for process equipment construction taking into account not only overall plant performance, but also improved safety, productivity, or capital expenditure.These factors include alternatives to stainless steel as lining material (glass, fluoropolymers, graphite, modified polymers), chem. compatibility, metallurgical and phys. factors, heat transfer properties, static electricity, equipment application and process conditions, and construction and maintenance factors.

Arkivoc

Indium trichloride catalyzed Ferrier rearrangement – Facile synthesis of 2,3-unsaturated glycosides

Author: Balasubramanian, K. K. ; Boga, S. B.

Treatment of tri-O-acetyl-D-glucal with various alcs. and phenols in the presence of InCl₃/CH₂Cl₂ at ambient temperature furnished the corresponding alkyl and aryl 2,3-unsaturated glycopyranosides in excellent yields in short reaction times and good anomeric selectivity.

1

News (Medical) associated with Shasun Pharmaceuticals Ltd.

28 Jan 2019

·www.business-standard.com

Strides Pharma Science to acquire 100% stake in Vensun Pharmaceutical, Inc.

Strides Pharma Science announced that its step down subsidiary Strides Pharma, Inc has on 29 January 2019 entered into an arrangement to acquire 100% stake in Vensun Pharmaceuticals, Inc.(Vensun), a US-based Generics Company. The board of directors of Strides have taken the same on record. Vensun was founded in 2011 with an asset-light partner-driven business model to develop products for the US generics markets. It entered into a partnership with the erstwhile Shasun Pharmaceuticals for a range of difficult to develop products on a 50:50 profit share arrangement Capital Market - Live News Click here to connect with us on WhatsApp Disclaimer: No Business Standard Journalist was involved in creation of this content

Acquisition

100 Deals associated with Shasun Pharmaceuticals Ltd.

Login to view more data

100 Translational Medicine associated with Shasun Pharmaceuticals Ltd.

Login to view more data

Corporation Tree

Boost your research with our corporation tree data.

login

or

view full example data

Boost your research with our corporation tree data.

Pipeline

Pipeline Snapshot as of 20 Feb 2025

The statistics for drugs in the Pipeline is the current organization and its subsidiaries are counted as organizations,Early Phase 1 is incorporated into Phase 1, Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3

Approved

1

Login to view more data